ArticleJournal of translational medicine2024

A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.

Lei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.